Annual Scientific Meeting

Excellence in Site Performance Awards

Sites participating in clinical trials play a crucial role in their conduct and delivery. We rely on the expertise, patient engagement and commitment of site staff to promote our research and recruit effectively, so that we improve outcomes for patients with GI cancer.

The Excellence in Site Performance Awards recognise clinical trial sites that have shown exceptional enthusiasm, performance and dedication to conducting GI Cancer Trials studies.

There are two categories:

Metropolitan
Regional, Rural and Remote

All clinical trial sites actively involved in GI Cancer Trials studies are encouraged to apply.

The successful sites will be announced at the 28th ASM in Nipaluna / Hobart. The recipients will receive two complimentary registrations to attend next year's ASM, recognition of achievement on the GI Cancer Trials website, member newsletter, and kudos from within the GI Cancer Trials network.

For any enquiries, please contact GI Cancer Trials.

Submit a nomination form

Submission deadline: Monday 7 September 2026, 9:00am AEST

Assessment criteria

Sites will be judged on the following criteria:

Willingness to participate in a wide range of GI Cancer Trials studies
Compliance with ICH GCP, local regulations and protocol
Willingness to participate in sub-studies
Site recruitment including patients from rural, regional and remote areas, Aboriginal and Torres Strait Islander communities, and culturally and linguistically diverse (CALD) backgrounds
Strategies employed to promote diverse clinical trial participation, including engagement with underrepresented and vulnerable populations
Current and future strategies to utilise teletrials
Willingness to engage in GI Cancer Trials strategies to promote equity, diversity and inclusion, including utilisation of e-Consent
Participant follow-up and high participation retention rates with minimal or no full withdrawal of consent
Engagement with the community
Patient and community feedback

Past recipients

2025 Metropolitan recipient:

Austin Health Cancer Clinical Trials GI Team

The award was accepted by Meg Donovan-Hayes and Professor Niall Tebbutt.

2025 Regional, Rural & Remote recipient:

Sunshine Coast University Hospital

The award was accepted by Dr Michael Allen.

2024 Metropolitan recipient:

Flinders Medical Centre